Moderna and Merck shares fall after possible data leak of melanoma vaccine information
Statements (9)
- Bearish
Moderna stock price fell 25% following a data leak regarding its cancer vaccine.
- Bearish
Moderna shares fell after a leak of cancer vaccine data despite positive results.
- Bearish
Moderna's stock tumbles after reported leak of data for cancer vaccine
- Bearish
BioNTech shares dropped following the same apparent early leak of melanoma vaccine data.
- Bearish
Moderna shares fell 25% after a melanoma vaccine data report appeared online and vanished within hours.
- Neutral
Pfizer shares edged higher after the same apparent early leak of melanoma vaccine data.
- Bearish
Moderna's stock price dropped after possible data leak regarding vaccine results.
- Bearish
Moderna stock crashed 20% after a third-party leaked purported cancer vaccine data.
- Bearish
Moderna and Merck shares fell following possible data leak regarding melanoma information